NATIONAL ANTIBIOTIC CAMPAIGN: “The Role of Research in Combating Antibiotic Resistance”
More than 200 scientists recently met in Rome at the EU conference on “The Role of Research in Combating Antibiotic Resistance". Antibiotics, once hailed as a panacea to combat bacterial infections, risk becoming more and more ineffective. The human body is responding less and less to antibiotics. New, more dangerous diseases, stubbornly resisting their power, are developing. The aim of the conference was to identify future research priorities to tackle the problem of anti-bacterial resistance and human health, addressing both basic and clinical research.
"People trust antibiotics to cure almost any kind of disease. Unfortunately, as recent outbreaks of Severe Acute Respiratory Syndrome (SARS) show, this is not the case,” says European Research Commissioner Philippe Busquin. “Antibiotic resistance is therefore the focus of research within the EU scientific funding programmes.
More research for the benefit of patients is needed to make use of the wealth of information provided by more than 140 bacterial genomes known today. We must also make sure that the pharmaceutical industry continues its research into the development of new antibiotics. With more than €100 million invested by the EU over the last four years in this field, we have supported more than 80 research projects on antimicrobial resistance. We will keep up the fight to find innovative answers to this problem. ”
Infectious diseases have the potential, like no other group of diseases, to spread rapidly over large distances in a short time. If no effective tools for treatment and prevention are available, they can dramatically change the lives of people and destabilise societies. The first antibiotic drugs became available in the wake of the Second World War, to save soldiers from deadly wounds. These powerful drugs soon became known as "wonder drugs" and were generously prescribed against minor bacterial infections or even viral infections, against which they have never been effective. Today, we pay the price for this complacency. In a recent Eurobarometer survey, Europeans were asked about their 'antibiotic habits': 38% of EU citizens had taken antibiotics in the last 12 months (45% of French and Spaniards but only 22% of Danes) out of whom 93% had a prescription.
Due to overuse and mis-use of these drugs, bacterial resistance to antibiotics is now accelerating at a disturbing rate worldwide. Previously effective antibiotics have lost their powers against a steadily growing list of resistant pathogens. As a result, the arsenal against severe, and often lethal, infectious diseases, like tuberculosis and pneumonia are rapidly diminishing.
Many pharmaceutical companies have pulled out from investments into research on new antimicrobial drugs. The expected sales revenues are no longer sufficient to make up for the costs linked to the development of these drugs. Many companies have instead refocused their efforts on the more profitable treatments for chronic diseases rather than short-course therapies for infections. This has contributed to making the situation worse.
On the other hand, considerable progress has been made in recent years to address these problems thanks to gene technology. Today, more than 140 bacterial genomes are known. However, knowledge of the genetic code of an organism does not in itself generate new drugs. In the light of these developments, plans for how to make the most of European-led research in the fight against antibiotic resistance need to be drawn up.
Malta was represented at the meeting by Michael A. Borg, Chairman of the National Antibiotic Committee. Commenting on the achievements of the congress, Dr. Borg said that the meeting of Europe’s top scientists in antibiotic use and resistance was successful in clarifying the state-of-the-art of present research and priorities needed in the subject, to identify the areas which are most suitable for antibiotic research in Europe at both EU level as well as at national level and to increase visibility of antibiotic research among scientists, clinicians, politicians and the general public.
The problem of antibiotic resistance is particularly relevant in the local setting, as research coordinated by the Infection Control Unit of the Health Department has pinpointed evidence of widespread incorrect use of antibiotics. To this end the National Antibiotic Committee has launched a campaign aimed at fostering better knowledge of these issues in the general public. The objective is to make the general public aware of the hazards of antibiotic abuse and encourage them to avoid taking antibiotics without medical prescriptions or putting pressure on medical doctors to prescribe antibiotics for conditions where antibiotics are known to be ineffective. It is only by encouraging such change that the use and abuse of antibiotics can be reduced.
A poster has been published and disseminated to encourage more sensible use of antibiotics. The Committee has also printed a leaflet in both Maltese and English containing answers to frequently asked questions about antibiotic use, especially for colds and other common infections. The leaflet is available at Centru Tagħrif dwar Saħħtek, St. John Street, Valletta or by contacting the National Antibiotic Committee on telephone 25951659 or email: peter.zarb@gov.mt.
Stqarrijiet Oħra:
PR261936
STQARRIJA MILL-UFFIĊĊJU TAD-DEPUTAT PRIM MINISTRU U MINISTERU GĦAS-SAĦĦA I...
PR261935en